BioCentury on BioBusiness,
ASCO, payers taking different paths to cancer payment reform
Related tables, figures and sidebars
Monday, June 2, 2014
Society of Clinical Oncology has made drug prices and value a
centerpiece of its annual meeting this week, but its newly unveiled payment
model doesn't yet address how physician practices actually should be paid for
drugs. Instead, payers are the ones taking the lead on new models that remove
or lessen incentives to prescribe IV drugs to boost oncologist profits.
On May 5, ASCO proposed a payment
model that includes five different bundled payments that are intended to
compensate doctors for services they currently provide but aren't reimbursed
for, such as financial and nutritional counseling and phone calls with patients
to address drug side effects.
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2014 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial 4 Weeks of Access
Get a 4-week free trial subscription to see the important articles you are missing.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]